Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 5OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1Febrile Neutropenia 1

Interventions

pegylated granulocyte colony-stimulating factor 3pegfilgrastim 3Vancomycin 3Linezolid 2Filgrastim 2ceftolozane, tazobactam drug combination 1Teicoplanin 1Sodium Chloride 1Piperacillin, Tazobactam Drug Combination 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Meropenem 1Itraconazole 1Cefepime 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Febrile Neutropenia × Meropenem × Clear all
NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Forest Laboratories

Phase 2 Terminated
2 enrolled 2 charts
Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡